Genedrive plc (GB:GDR) has released an update.
Genedrive plc, a UK-based pharmacogenetic testing company, has announced changes to its financial offering schedules, extending its Open Offer and REX Retail Offer deadlines to allow investors more time to participate. The updated Open Offer timetable indicates final deadlines in late May 2024, aligning with the REX Retail Offer for a synchronized closing date. Genedrive is known for its rapid, low-cost genetic testing kits that aid clinicians in emergency healthcare by providing quick genetic information to personalize medication choices.
For further insights into GB:GDR stock, check out TipRanks’ Stock Analysis page.
